Retrophin

Retrophin

Retrophin

Retrophin is a biopharmaceutical company focused on the discovery and development of drugs for the treatment of catastrophic diseases.
Founded
2011
Raised
$91M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$45,000,000
Post-IPO debt - 2014
$46,000,000
Convertible Note - 2014
Team Size
50+
Employees
Xconomy

Retrophin Sinks as Drug “Pharma Bro” Martin Shkreli Co-Invented Fails

Xconomy

Retrophin Drug Licensed by Shkreli Shows Positive Phase 2 Results

Health
The Motley Fool

Why Retrophin Inc was Down Today

Health Stock markets
The Motley Fool

Why Retrophin's Shares Are Crashing Today --

Technology Stock markets